Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

4 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Unravelling Eribulin's role in metastatic breast cancer: evaluating benefits for both triple negative and non-triple negative patients in real-world scenarios in resource-constrained settings.
Kapoor A, Gupta A, Sansar B, Gupta P, Mishra BK, Singh A, Upadhyay A, Kumar A, Tripathi M, Chowdhury Z, Patne S, Dhal I, Singh N, Shukla S, Singh SN, Pujari L, Giridhar P, Kapoor AR, Jain Y, Venkatachalam M, Dey S, Vinayak KR. Kapoor A, et al. Among authors: vinayak kr. Ecancermedicalscience. 2024 Nov 28;18:1804. doi: 10.3332/ecancer.2024.1804. eCollection 2024. Ecancermedicalscience. 2024. PMID: 39816379 Free PMC article.
A physiotherapists perspective of a geriatric clinic in a tertiary oncology centre.
Chitre A, Kapoor A, Sansar B, Gupta A, Lakshmanamurthy P, Dey S, Vinayak K, Sahoo A, Kaur N, Azeem S, Kadu D, Shrivastav AA. Chitre A, et al. Ecancermedicalscience. 2024 Sep 20;18:1774. doi: 10.3332/ecancer.2024.1774. eCollection 2024. Ecancermedicalscience. 2024. PMID: 39430086 Free PMC article.
Docetaxel-oxaliplatin-capecitabine/5-fluorouracil (DOX/F) followed by docetaxel versus oxaliplatin-capecitabine/5-fluorouracil (CAPOX/FOLFOX) in HER2-negative advanced gastric cancers.
Ramaswamy A, Bhargava P, Dubashi B, Gupta A, Kapoor A, Srinivas S, Shetty O, Jadhav P, Desai V, Noronha V, Joshi A, Menon N, Patil VM, Mishra BK, Sansar B, Singh A, Patel S, Singh SN, Dhal I, Vinayak KR, Pal V, Mandavkar S, Kannan S, Chaugule D, Patil R, Parulekar M, Nashikkar C, Ankathi SK, Kaushal RK, Shah A, Ganesan P, Kayal S, Ananthakrishnan R, Syed N, Samaddar D, Kapu V, Shah A, Kaaviya D, Suganiya R, Srinivasan ND, Prabhash K, Ostwal V. Ramaswamy A, et al. Among authors: vinayak kr. JNCI Cancer Spectr. 2024 Jul 1;8(4):pkae054. doi: 10.1093/jncics/pkae054. JNCI Cancer Spectr. 2024. PMID: 39067037 Free PMC article. Clinical Trial.